Intervention Protocol

Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma

  1. Athanassios Kyrgidis1,2,3,*,
  2. Thrasivoulos Tzellos4,
  3. Simone Mocellin5,
  4. Zoe Apalla6,
  5. Aimilios Lallas7,
  6. Pierluigi Pilati5,
  7. Alexander Stratigos8

Editorial Group: Cochrane Skin Group

Published Online: 31 JAN 2013

DOI: 10.1002/14651858.CD010307


How to Cite

Kyrgidis A, Tzellos T, Mocellin S, Apalla Z, Lallas A, Pilati P, Stratigos A. Sentinel lymph node biopsy followed by lymph node dissection for early cutaneous melanoma (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD010307. DOI: 10.1002/14651858.CD010307.

Author Information

  1. 1

    Dessau Medical Center, Division of Evidence Based Dermatology, Dessau, Germany

  2. 2

    Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

  3. 3

    Aristotle University of Thessaloniki, Otolaryngology Head & Neck Surgery, Thessaloniki, Greece

  4. 4

    Faculty of Health Sciences, University Hospital of Northern Norway, Department of Dermatology, Harstad, Troms, Norway

  5. 5

    University of Padova, Meta-Analysis Unit, Department of Surgery, Oncology and Gastroenterology, Padova, Veneto, Italy

  6. 6

    Hospital of Skin and Venereal Diseases, State Clinic of Dermatology, Thessaloniki, Greece

  7. 7

    Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Dermatology and Skin Cancer Unit, Reggio Emilia, Italy

  8. 8

    Andreas Sygros Hospital, Department of Dermatology, National and Kapodistrian University of Athens, Athens, Greece

*Athanassios Kyrgidis, akyrgidi@gmail.com. kyrgidis@auth.gr.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 JAN 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects and safety of SLNB and completion lymph node dissection (CLND) for the treatment of early melanoma.

We will also try to elucidate any potential survival advantage of SLNB according to primary tumour thickness to justify the current clinical practice of performing SLNB according to thickness, and we aim to identify baseline factors that may affect rate of recurrence and distant metastasis.